These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

487 related items for PubMed ID: 23019289

  • 1. Safely ruling out inflammatory bowel disease in children and teenagers without referral for endoscopy.
    Van de Vijver E, Schreuder AB, Cnossen WR, Muller Kobold AC, van Rheenen PF, North Netherlands Pediatric IBD Consortium.
    Arch Dis Child; 2012 Dec; 97(12):1014-8. PubMed ID: 23019289
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic Accuracy of Fecal Calprotectin for Pediatric Inflammatory Bowel Disease in Primary Care: A Prospective Cohort Study.
    Holtman GA, Lisman-van Leeuwen Y, Kollen BJ, Norbruis OF, Escher JC, Kindermann A, de Rijke YB, van Rheenen PF, Berger MY.
    Ann Fam Med; 2016 Sep; 14(5):437-45. PubMed ID: 27621160
    [Abstract] [Full Text] [Related]

  • 3. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis.
    van Rheenen PF, Van de Vijver E, Fidler V.
    BMJ; 2010 Jul 15; 341():c3369. PubMed ID: 20634346
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of point-of-care test calprotectin and lactoferrin for inflammatory bowel disease among children with chronic gastrointestinal symptoms.
    Holtman GA, Lisman-van Leeuwen Y, van Rheenen PF, Kollen BJ, Escher JC, Kindermann A, de Rijke YB, Berger MY.
    Fam Pract; 2017 Aug 01; 34(4):400-406. PubMed ID: 27535331
    [Abstract] [Full Text] [Related]

  • 5. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB, Terrin G, Rapacciuolo L, Miele E, Siani MC, Puzone C, Cosenza L, Staiano A, Troncone R.
    Dig Liver Dis; 2008 Jul 01; 40(7):547-53. PubMed ID: 18358796
    [Abstract] [Full Text] [Related]

  • 6. Faecal calprotectin in children with clinically quiescent inflammatory bowel disease.
    Sipponen T, Kolho KL.
    Scand J Gastroenterol; 2010 Aug 01; 45(7-8):872-7. PubMed ID: 20377469
    [Abstract] [Full Text] [Related]

  • 7. Fecal calprotectin: a selection tool for small bowel capsule endoscopy in suspected IBD with prior negative bi-directional endoscopy.
    Koulaouzidis A, Douglas S, Rogers MA, Arnott ID, Plevris JN.
    Scand J Gastroenterol; 2011 May 01; 46(5):561-6. PubMed ID: 21269246
    [Abstract] [Full Text] [Related]

  • 8. Primary care faecal calprotectin testing in children with suspected inflammatory bowel disease: a diagnostic accuracy study.
    Walker GJ, Chanchlani N, Thomas A, Lin S, Moore L, Heerasing NM, Hendy P, Abdelrahim M, Mole S, Perry MH, Mcdonald TJ, Bewshea CM, Hart JW, Russell RK, Ahmad T, Goodhand JR, Kennedy NA.
    Arch Dis Child; 2020 Oct 01; 105(10):957-963. PubMed ID: 32424002
    [Abstract] [Full Text] [Related]

  • 9. Predicting inflammatory bowel disease in children with abdominal pain and diarrhoea: calgranulin-C versus calprotectin stool tests.
    Heida A, Van de Vijver E, van Ravenzwaaij D, Van Biervliet S, Hummel TZ, Yuksel Z, Gonera-de Jong G, Schulenberg R, Muller Kobold A, van Rheenen PF, CACATU consortium.
    Arch Dis Child; 2018 Jun 01; 103(6):565-571. PubMed ID: 29514815
    [Abstract] [Full Text] [Related]

  • 10. Selecting children with suspected inflammatory bowel disease for endoscopy with the calgranulin C or calprotectin stool test: protocol of the CACATU study.
    Heida A, Van de Vijver E, Muller Kobold A, van Rheenen P.
    BMJ Open; 2017 May 29; 7(5):e015636. PubMed ID: 28554936
    [Abstract] [Full Text] [Related]

  • 11. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.
    Kolho KL, Raivio T, Lindahl H, Savilahti E.
    Scand J Gastroenterol; 2006 Jun 29; 41(6):720-5. PubMed ID: 16716972
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic accuracy and clinical application of faecal calprotectin in adult patients presenting with gastrointestinal symptoms in primary care.
    Pavlidis P, Chedgy FJ, Tibble JA.
    Scand J Gastroenterol; 2013 Sep 29; 48(9):1048-54. PubMed ID: 23883068
    [Abstract] [Full Text] [Related]

  • 13. VAlidation of an 8-item-questionnaire predictive for a positive caLprotectin tEst and Real-life implemenTation in primary care to reduce diagnostic delay in inflammatory bowel disease (ALERT): protocol for a prospective diagnostic study.
    Hasler S, Zahnd N, Müller S, Vavricka S, Rogler G, Tandjung R, Rosemann T.
    BMJ Open; 2015 Mar 10; 5(3):e007306. PubMed ID: 25757949
    [Abstract] [Full Text] [Related]

  • 14. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.
    Kaiser T, Langhorst J, Wittkowski H, Becker K, Friedrich AW, Rueffer A, Dobos GJ, Roth J, Foell D.
    Gut; 2007 Dec 10; 56(12):1706-13. PubMed ID: 17675327
    [Abstract] [Full Text] [Related]

  • 15. [Calprotectin: a fecal marker for diagnosis and follow-up in patients with chronic inflammatory bowel disease].
    van den Bergh FA, Kolkman JJ, Russel MG, Vlaskamp RT, Vermes I.
    Ned Tijdschr Geneeskd; 2003 Nov 29; 147(48):2360-5. PubMed ID: 14677476
    [Abstract] [Full Text] [Related]

  • 16. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.
    Waugh N, Cummins E, Royle P, Kandala NB, Shyangdan D, Arasaradnam R, Clar C, Johnston R.
    Health Technol Assess; 2013 Nov 29; 17(55):xv-xix, 1-211. PubMed ID: 24286461
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic work-up of inflammatory bowel disease in children: the role of calprotectin assay.
    Diamanti A, Panetta F, Basso MS, Forgione A, Colistro F, Bracci F, Papadatou B, Francalanci P, Torroni F, Knafelz D, Fina F, Castro M.
    Inflamm Bowel Dis; 2010 Nov 29; 16(11):1926-30. PubMed ID: 20310017
    [Abstract] [Full Text] [Related]

  • 18. How to use faecal calprotectin in management of paediatric inflammatory bowel disease.
    Saha A, Tighe MP, Batra A.
    Arch Dis Child Educ Pract Ed; 2016 Jun 29; 101(3):124-8. PubMed ID: 26848103
    [Abstract] [Full Text] [Related]

  • 19. Clinical usefulness of the faecal calprotectin test in suspected paediatric inflammatory bowel disease.
    Akobeng AK.
    Acta Paediatr; 2018 Nov 29; 107(11):2019-2023. PubMed ID: 29706011
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome.
    Otten CM, Kok L, Witteman BJ, Baumgarten R, Kampman E, Moons KG, de Wit NJ.
    Clin Chem Lab Med; 2008 Nov 29; 46(9):1275-80. PubMed ID: 18597588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.